The conventional paradigm of nonalcoholic fatty liver disease representing the “hepatic
manifestation of the metabolic syndrome” is outdated. We identified and summarized …

Context: An excess circulating uric acid level, even within the normal range, is always
comorbid with metabolic syndrome (MS), several of its components, and nonalcoholic fatty …

Background and aim Accumulating clinical evidence suggests that hyperuricemia is strongly
associated with abnormal glucose metabolism and insulin resistance. However, how high …

El síndrome metabólico (SM) es un desorden clínico que se caracteriza por presentar
obesidad abdominal, hipertensión, dislipidemia y resistencia a la insulina. El SM es un …

Emerging evidence has shown that serum uric acid (SUA) elevation might cause metabolic
derangements, including metabolic syndrome (MetS) and non-alcoholic fatty liver disease …

Background: The purpose of this meta-analysis was to determine if uric acid-lowering
therapy is associated with a decrease in blood pressure (BP) and serum creatinine levels …

Background Some observational studies have suggested that serum uric acid (SUA) levels
are one of the determinants of the metabolic syndrome (MetS). However, previous studies …

Purpose This study aimed to assess the relationship of serum uric acid with metabolic
syndrome and its components in Tibetan adults on the Tibetan plateau. Methods A total of …

Hyperuricemia is associated with many metabolic diseases. However, the underlying
mechanism remains unknown. The gut microbiota has been demonstrated to play significant …

Hyperuricaemia is a disorder of purine metabolism, and is strongly associated with insulin
resistance and abnormal glucose metabolism. As the producer of insulin, pancreatic β cells …